More Recce Pharmaceuticals Ltd. news Recce Pharmaceuticals Ltd.ASX: RCE R327 Efficacy against WHO Priority Pathogen Acinetobacter B Jul 8, 2024 at 4:14 AM UTC As issuedPlain English Recce Ltd has released a press release. View Attachment
